Alpha thymosin peptides as cancer vaccine adjuvants

Details for Australian Patent Application No. 2005314271 (hide)

Owner SciClone Pharmaceuticals, Inc.

Inventors Rudolph, Alfred R.; Moviglia, Gustavo Antonio

Agent Wrays

Pub. Number AU-B-2005314271

PCT Pub. Number WO2006/062917

Priority 60/633,175 06.12.04 US

Filing date 6 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 16 June 2011

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

26 July 2007 PCT application entered the National Phase

  PCT publication WO2006/062917 Priority application(s): WO2006/062917

16 June 2011 Application Accepted

  Published as AU-B-2005314271

13 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005314273-Garment backpack

2005314268-Graphical user interface for 3-D in-vivo imaging